Immunocore Holdings (IMCR) Income towards Parent Company (2023 - 2026)

Immunocore Holdings has disclosed Income towards Parent Company across 4 years of filings, most recently posting $13.0 million for Q1 2026.

• Income towards Parent Company for Q1 2026 came in at $13.0 million, up 160.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$27.6 million (down 27.08% YoY), and the FY2025 annual result was -$35.5 million, up 30.48% from the prior year.
• Income towards Parent Company came in at $13.0 million for Q1 2026 at Immunocore Holdings, up from -$30.1 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $13.0 million in Q1 2026 to a low of -$30.1 million in Q4 2025.
• The 4-year median for Income towards Parent Company is -$11.6 million (2024), against an average of -$9.9 million.
• Across the five-year window, Income towards Parent Company soared 859.49% in 2024 and plunged 102.04% in 2025, its largest moves.
• Immunocore Holdings' Income towards Parent Company stood at -$19.7 million in 2023, then dropped by 20.48% to -$23.8 million in 2024, then dropped by 26.66% to -$30.1 million in 2025, then surged by 143.08% to $13.0 million in 2026.
• The last three Income towards Parent Company figures came in at $13.0 million (Q1 2026), -$30.1 million (Q4 2025), and -$177000.0 (Q3 2025), per Business Quant data.